The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2024
Filed:
Nov. 30, 2022
Applicant:
Krystal Biotech, Inc., Pittsburgh, PA (US);
Inventor:
Suma Krishnan, Pittsburgh, PA (US);
Assignee:
Krystal Biotech, Inc., Pittsburgh, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/763 (2015.01); A61K 9/00 (2006.01); A61K 38/17 (2006.01); A61K 38/39 (2006.01); A61K 48/00 (2006.01); C07K 14/78 (2006.01); C12N 9/02 (2006.01); A61K 9/06 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 35/763 (2013.01); A61K 9/0014 (2013.01); A61K 38/1748 (2013.01); A61K 38/39 (2013.01); A61K 48/005 (2013.01); C07K 14/78 (2013.01); C12N 9/0071 (2013.01); C12Y 114/11004 (2013.01); A61K 9/06 (2013.01); A61K 47/38 (2013.01); C12N 2710/16643 (2013.01);
Abstract
Provided herein are methods of delivering transgenes to an eye of a subject comprising the use of pharmaceutical compositions having one or more polynucleotides suitable for enhancing, increasing, augmenting, and/or supplementing the levels of the transgene in the eye. Also provided herein are methods of correcting vision loss in a subject in need thereof comprising the use of the pharmaceutical compositions described herein.